Holen Sie sich die Stockscreener-App
416.23
0.99%
-4.16
Überblick
Nachrichten
Preisverlauf
Optionskette
Financials
Warum fällt ELV?
Forum
Prognose
Aktiensplit
Dividendenhistorie
Schlusskurs vom Vortag:
$420.39
Offen:
$420.08
24-Stunden-Volumen:
779.52K
Relative Volume:
0.46
Marktkapitalisierung:
$90.39B
Einnahmen:
$200.42B
Nettoeinkommen (Verlust:
$5.24B
KGV:
17.71
EPS:
23.5042
Netto-Cashflow:
$6.45B
1W Leistung:
-0.40%
1M Leistung:
+2.88%
6M Leistung:
+11.64%
1J Leistung:
+20.35%
1-Tages-Spanne:
$415.49
$422.06
1-Wochen-Bereich:
$406.91
$427.64
52-Wochen-Spanne:
$273.71
$427.64
Elevance Health Inc Stock (ELV) Company Profile
Firmenname
Elevance Health Inc
Sektor
Branche
Telefon
(800) 331-1476
Adresse
220 VIRGINIA AVENUE, INDIANAPOLIS
Compare ELV vs UNH, CVS, CI, HUM
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
ELV
Elevance Health Inc
|
416.23 | 90.39B | 200.42B | 5.24B | 6.45B | 23.50 |
UNH
Unitedhealth Group Inc
|
424.62 | 385.62B | 449.71B | 12.81B | 19.67B | 13.24 |
CVS
Cvs Health Corp
|
104.15 | 132.89B | 407.94B | 2.90B | 7.39B | 2.2771 |
CI
Cigna Group
|
293.46 | 77.63B | 278.13B | 6.74B | 7.66B | 23.60 |
HUM
Humana Inc
|
392.22 | 47.09B | 137.20B | 1.15B | 1.27B | 9.3439 |
Elevance Health Inc Stock (ELV) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2026-04-08 | Eingeleitet | Evercore ISI | In-line |
| 2026-02-03 | Herabstufung | RBC Capital Mkts | Outperform → Sector Perform |
| 2026-01-08 | Hochstufung | Wolfe Research | Peer Perform → Outperform |
| 2025-12-19 | Herabstufung | Deutsche Bank | Buy → Hold |
| 2025-10-14 | Eingeleitet | Goldman | Neutral |
| 2025-07-21 | Herabstufung | Argus | Buy → Hold |
| 2025-07-18 | Herabstufung | Leerink Partners | Outperform → Market Perform |
| 2025-04-15 | Herabstufung | Robert W. Baird | Outperform → Neutral |
| 2025-03-17 | Hochstufung | Argus | Hold → Buy |
| 2025-01-22 | Herabstufung | Stephens | Overweight → Equal-Weight |
| 2024-10-18 | Herabstufung | Argus | Buy → Hold |
| 2024-07-18 | Herabstufung | BofA Securities | Buy → Neutral |
| 2024-06-24 | Eingeleitet | Morgan Stanley | Overweight |
| 2024-05-30 | Eingeleitet | Robert W. Baird | Outperform |
| 2024-03-06 | Eingeleitet | Barclays | Overweight |
| 2023-07-12 | Herabstufung | Wolfe Research | Outperform → Peer Perform |
| 2023-04-27 | Hochstufung | Morgan Stanley | Equal-Weight → Overweight |
| 2023-04-21 | Eingeleitet | Cantor Fitzgerald | Overweight |
| 2023-03-28 | Hochstufung | RBC Capital Mkts | Sector Perform → Outperform |
| 2022-09-09 | Hochstufung | BofA Securities | Neutral → Buy |
| 2022-08-22 | Hochstufung | SVB Leerink | Mkt Perform → Outperform |
Alle ansehen
Elevance Health Inc Aktie (ELV) Neueste Nachrichten
Should Elevance Health’s (ELV) Index Shift and Softer Outlook Require Action From Investors? - Yahoo Finance
St. Louis Alzheimer's diagnostics company lands first U.S. insurance coverage - The Business Journals
Is ELV's Capital Allocation Strategy Creating Long-Term Value? - TradingView
Can UNH's Lifestyle Spending Account Redefine Employee Benefits? - TradingView
Elevance Health stock steadies as investors await the next update - AD HOC NEWS
Wellpoint out as D.C. Medicaid provider; AmeriHealth Caritas D.C. taking over - The Business Journals
Elevance Health Inc. stock underperforms Thursday when compared to competitors despite daily gains - MarketWatch
Anthem partners with 1si to lower cost of health coverage for small businesses - News and Tribune
Elevance Health stock: Is ELV underperforming the health care sector? - MSN
Elevance Health stock hits 52-week high at 427.49 USD By Investing.com - Investing.com India
Elevance Health stock hits 52-week high at 427.49 USD - Investing.com
Can Centene's Operational Execution Keep Margin Recovery on Track? - TradingView
RBC Adjusts Price Target on Elevance Health to $439 From $358, Maintains Sector Perform Rating - marketscreener.com
CADEN CAPITAL PARTNERS, LP's Elevance Health Inc(ELV) Holding History - GuruFocus
Elevance Health options suggest 5.6% move on July 15 earnings By Investing.com - Investing.com South Africa
Elevance Health options suggest 5.6% move on July 15 earnings - Investing.com
Analysts Estimate Elevance Health (ELV) to Report a Decline in Earnings: What to Look Out for - Yahoo Finance
Elevance Health's Q2 2026 earnings: What to expect - MSN
Elevance Health stock holds focus on its business model. - AD HOC NEWS
Elevance Health Expands Access to Digital Tools, Helping Bridge the Healthcare Digital Divide - AOL.com
Elevance Sues CMS Over Star Ratings, Seeks Same Recalculation Applied to Clover - MedCity News
Form 144 Elevance Health For: 7 July By Investing.com - Investing.com Nigeria
[144] Elevance Health, Inc. SEC Filing - Stock Titan
Elevance Health Inc. stock outperforms competitors on strong trading day - MarketWatch
Elevance Health Announces $640 Million Investment in Affordable Housing Over the Past Five Years, Surpassing $1 Billion in Total Commitment Nationwide - AOL.com
Cantor Fitzgerald Adjusts Elevance Health Price Target to $450 From $400 - Moomoo
Elevance Health Is Maintained at Overweight by Cantor Fitzgerald - Moomoo
Evercore ISI Adjusts Price Target on Elevance Health to $440 From $360 - Moomoo
Elevance Health highlights managed care strategy as investors track S&P 500 exposure - AD HOC NEWS
Elevance Health to discuss Q2FY26 results on July 15 - scanx.trade
Press Release: Elevance Health to Hold Conference Call and Webcast to Discuss Second Quarter 2026 Results on July 15, 2026 - Moomoo
Elevance Health shapes its insurance and benefits profile as investors weigh long-term growth - AD HOC NEWS
Elevance Health Inc. stock underperforms Monday when compared to competitors - MarketWatch
Elevance Health sets July 15 call on Q2 2026 results - Stock Titan
T. Rowe Price Global Allocation Fund's Elevance Health Inc(ELV) Holding History - GuruFocus
UnitedHealth Bets on Profitability Over Growth: Will It Pay Off? - TradingView
Can Centene's Fraud Prevention Strategy Support Margin Recovery? - TradingView
Insurer Elevance Seeks Recalculated Medicare Star Rating in Lawsuit - Benzinga
Elevance Health focuses on managed care growth and digital health strategy - AD HOC NEWS
Anthem Blue Cross and Blue Shield and USA TODAY Launch Video Series to Help Americans Navigate Health Care - Financial Times
Elevance Health, Inc. (ELV) Stock Analysis: Navigating a Solid Healthcare Play with a 0.85% Upside Potential - DirectorsTalk Interviews
T. Rowe Price Moderate Allocation Portfolio's Elevance Health Inc(ELV) Holding History - GuruFocus
Elevance Health focuses on managed care strategy as a major US insurer - AD HOC NEWS
ELVElevance Health Inc Latest SEC Filings - Finviz
Elevance Health (ELV) Sues CMS Over Medicare Ratings And Lost Bonus Payments - Yahoo Finance
Can Elevance Health (ELV) Stay Below Fair Value After A 23% Gain? - Yahoo Finance
Can Elevance Recover $115 Million Through Its CMS Lawsuit? - Yahoo Finance
The Unpopular Move That Telegraphed the Elevance Health Stock Surge - Yahoo Finance
Elevance Health sues over Medicare Advantage star ratings - Modern Healthcare
Elevance sues government over $115 million tied to Medicare Advantage star ratings - STAT
Elevance Health stock hits 52-week high at 427.07 USD By Investing.com - Investing.com South Africa
Finanzdaten der Elevance Health Inc-Aktie (ELV)
Umsatz
Nettogewinn
Free Cashflow
ENV
Elevance Health Inc-Aktie (ELV) Insiderhandel
| Insiderhandel | Beziehung | Datum | Transaktion | Kosten | #Aktien | Wert ($) | #Aktien Gesamt |
|---|---|---|---|---|---|---|---|
| Penczek Ronald W | CAO & Controller |
Jun 12 '26 |
Sale |
403.16 |
369 |
148,766 |
3,740 |
0.57%
1.39%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):